The diagnostic accuracy of PI-RADS v2 for clinically significant cancer was evaluated by using whole-mount step-section slides as standard of reference. All significant cancers could be identified and the accuracy of PI-RADS 3 to 5 for predicting significant cancer was 91.7%, with high sensitivity (100%) and negative predictive value (100%).
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords